Enhanced Expression of Plasminogen Activator Inhibitor 1 in Patients with Nephrotic Syndrome

Publisher： Karger

E-ISSN： 2235-3186|88|1|24-29

ISSN： 1660-8151

Source： Nephron, Vol.88, Iss.1, 2001-04, pp. : 24-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue-Type Plasminogen Activator (tPA) and Its Inhibitor (PAI-1) in Patients Treated with Continuous Ambulatory Peritoneal Dialysis

By  

American Journal of Nephrology, Vol. 18, Iss. 3, 1998-05 ,pp. : 186-192

Karger

Access to resources Recommend Favorite

Poly(ADP-Ribose) Polymerase-1 Mediates Angiotensin II-Induced Expression of Plasminogen Activator Inhibitor-1 and Fibronectin in Rat Mesangial Cells

By  

Kidney and Blood Pressure Research, Vol. 34, Iss. 5, 2011-05 ,pp. : 320-327

Karger

Access to resources Recommend Favorite

Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 19, Iss. 4, 1999-08 ,pp. : 492-494

Karger

Access to resources Recommend Favorite

Hyporeninemic Hypoaldosteronism in Patients with Nephrotic Syndrome

By  

American Journal of Nephrology, Vol. 18, Iss. 3, 1998-05 ,pp. : 251-255

Karger

Access to resources Recommend Favorite

Platelet Activation Markers in Patients with Nephrotic Syndrome

By  

Nephron, Vol. 91, Iss. 3, 2002-07 ,pp. : 424-430

Karger

Access to resources Recommend Favorite